Entera Bio (ENTX) announced highlights from Dr. Rachel B Wagman’s oral presentation at the 2025 World Congress on Osteoporosis, Osteoarthritis ...

Holdings announced the execution of a merger agreement with 20/20 BioLabs to combine the companies in an all-stock ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

This would require greater innovation, incentives for scaling-up of bio-based solutions, and the removal of policy and infrastructure bottlenecks. Addressing the regional imbalance would also be ...

MLB Opening Day 2025 is finally upon us and all eyes will be on the Los Angeles Dodgers after their World Series win in 2024. The Dodgers technically already opened their season with a sweep of ...

One of the biotech in­dus­try’s most well-fund­ed cell and gene ther­a­py com­pa­nies has laid off em­ploy­ees for the third year in a row.

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...

Boston-based Hill­star Bio on Tues­day be­came the lat­est im­munol­o­gy start­up launch, un­veil­ing a $67 mil­lion Se­ries A round ...

Hillstar Bio is revolutionizing autoimmune disease treatment through a precision-driven approach that selectively depletes pathogenic cells while preserving healthy ones. This method holds the ...

Hillstar Bio is revolutionizing autoimmune disease treatment through a precision-driven approach that selectively depletes pathogenic cells while preserving healthy ones. This method holds the promise ...

Funding will support two Phase 2 clinical trials in alcohol and cocaine use disorders Company has initiated Phase 2 study in alcohol use disorder and plans to initiate cocaine studies over the ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...